Taizhou Xingputai Biopharmaceutical Co., LTD., based on the key research and development direction of peptide drugs planned by "Made in China 2025" and the strategic deployment of the "13th Five-Year Plan" biological industry Development Plan, is committed to providing integrated research and development and production services for global customers of innovative peptide drugs, and developing innov...